Evidence map›Paper›PMID 28941056›Full record

Trial reportJournal of clinical hypertension (Greenwich, Conn.)2017

Mobile phone text messaging improves antihypertensive drug adherence in the community.

Paola Varleta, Mónica Acevedo, Carlos Akel, Claudia Salinas, Carlos Navarrete, Ana García, Carolina Echegoyen, Daniel Rodriguez, Lissette Gramusset, Sandra Leon and 3 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical hypertension (Greenwich, Conn.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 11 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 11 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Description of patient questions received by clinical pharmacists in the Nudge Study.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2023
    Trial
  19. Trial
  20. Effect ofPrimary health care research & development · 2022
    Trial
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Paola VarletaFundación de la Sociedad Chilena de Cardiología y Cirugía Cardiovascular, Santiago, Chile.
Mónica AcevedoFundación de la Sociedad Chilena de Cardiología y Cirugía Cardiovascular, Santiago, Chile.
Carlos AkelFundación de la Sociedad Chilena de Cardiología y Cirugía Cardiovascular, Santiago, Chile.
Claudia SalinasFundación de la Sociedad Chilena de Cardiología y Cirugía Cardiovascular, Santiago, Chile.
Carlos NavarreteDepartamento de Matemáticas, Facultad de Ciencias, Universidad de la Serena, La Serena, Chile.
Ana GarcíaCentro de Salud Familiar Ossandón, Santiago, Chile.
Carolina EchegoyenCentro de Salud Familiar Santa Amalia, Santiago, Chile.
Daniel RodriguezCentro de Salud Familiar Presidenta Michelle Bachelet, Santiago, Chile.
Lissette GramussetCentro de Salud Familiar Gustavo Molina, Santiago, Chile.
Sandra LeonCentro de Salud Familiar Ignacio Domeiko, Santiago, Chile.
Pedro CofréCentro de Salud Familiar Dr. Anibal Ariztía, Santiago, Chile.
Raquel RetamalCentro de Salud Familiar Santa Julia, Santiago, Chile.
Katerine RomeroCentro de Salud Familiar Padre Gerardo Whelan, Santiago, Chile.
Fundación Chile · CLInstituto de Salud Pública de Chile · CLSociedad Andaluza de Medicina Familiar y Comunitaria · ESHospital Dipreca · CLHospital Dr. Gustavo Fricke · CLHospital Padre Hurtado · CLUniversity of La Serena · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antihypertensive drug adherence (ADA) is a mainstay in blood pressure control. Education through mobile phone short message system (SMS) text messaging could improve ADA. The authors conducted a randomized study involving 314 patients with hypertension with <6 months of antihypertensive treatment from the Preventive Health Program of 12 different primary care centers in Santiago, Chile. Patients were randomly assigned to receive or not receive SMS related to ADA and healthy lifestyle. Adherence was assessed by the self-reported four-item scale Morisky-Green-Levine questionnaire at baseline and after 6 months of follow-up, with four of four positive questions classified as good adherence. Group comparison for adherence was performed by means of a logistic regression model, adjusting by baseline adherence, age older than 60 years, and sex. A total of 163 patients were randomized to receive and 151 to not receive SMS. After 6 months of follow-up, ADA in the non-SMS group decreased from 59.3% to 51.4% (P=.1). By contrast, adherence increased from 49% to 62.3% (P=.01) in the SMS group. Text messaging intervention improved ADA (risk ratio, 1.3; 95% confidence interval, 1.0-1.6 [P<.05]). At 6-month follow-up, text messaging resulted in an increase in reporting ADA in this hypertensive Latino population. This approach could become an effective tool to overcome poor medication adherence in the community.

Indexed as

Drug MonitoringHypertensionMedication AdherenceText MessagingAntihypertensive AgentsChileFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMedication Therapy ManagementMiddle AgedOutcome Assessment, Health CareReminder SystemsAntihypertensive Agentshypertensionmedication adherencepatient compliancetext messaging

Identifiers

PMID28941056
PMCPMC8031315
OpenAlexW2759825735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.